Keyphrases
1,25-dihydroxyvitamin D3
100%
1,25(OH)2D3
86%
Vitamin D
42%
Alendronate
26%
Osteoporosis
24%
Calcitriol
19%
Bone Mineral Density
18%
Rickets
16%
Breast Cancer Cells
16%
Tumor Necrosis Factor-α
15%
Skin Fibroblasts
15%
Lymphocytes
15%
Hypercalciuria
13%
Keratinocytes
12%
Reactive Oxygen Species
12%
Kindred
12%
Hereditary Hypophosphatemic Rickets with Hypercalciuria
12%
Cultured Skin
12%
Vertebral Fracture
10%
Vitamin D Receptor
10%
Postmenopausal Women
9%
Cytotoxicity
9%
High Dose
9%
D3 Receptor
9%
Quality of Life
9%
Hip Fracture
9%
Prostaglandin E2
8%
Inhibitory Effect
8%
Mitogenesis
8%
Postmenopausal Osteoporosis
7%
Meta-analysis
7%
Hereditary Vitamin D-resistant Rickets (HVDRR)
7%
Idiopathic Hypercalciuria
7%
Fibroblasts
7%
Mitochondria
7%
Exocytosis
7%
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3)
7%
Vitamin D3
7%
Human Lymphocytes
6%
Caspase-dependent
6%
Phosphate
6%
Vitamin D Deficiency
6%
Nuclear Uptake
6%
End Organ
6%
Fracture Risk
6%
Bisphosphonates
6%
Hypophosphatemia
6%
Lymphokine-activated Killer Cells
6%
Calpain
6%
Hypoparathyroidism
6%
Pharmacology, Toxicology and Pharmaceutical Science
Calcitriol
55%
Vitamin D
37%
Alendronic Acid
27%
Tumor Necrosis Factor
19%
Breast Cancer
19%
Rickets
14%
Placebo
13%
Glucocorticoid
13%
Spine Fracture
13%
Receptor
12%
Reactive Oxygen Metabolite
11%
Disease
10%
Syndrome
10%
Hip Fracture
9%
Vitamin D Receptor
7%
Caspase
7%
Alopecia
6%
Hypercalciuria
6%
Epileptic Absence
6%
Bisphosphonic Acid Derivative
6%
Adenosine
6%
Calpain
6%
Cytokine
5%
Hypocalcaemia
5%
Prostaglandin E2
5%
Biochemistry, Genetics and Molecular Biology
Vitamin D
31%
Rickets
23%
Eicosanoid Receptor
19%
Cancer Cell
19%
Fibroblast
19%
Calcitriol
13%
Tumor Necrosis Factor
12%
Parathyroid Hormone
10%
Hypercalciuria
9%
Cell Death
8%
Bone Density
7%
Ergocalciferol
7%
Lymphocyte
7%
Caspase
7%
Cytotoxicity
6%
Drug Megadose
6%
Cyclic Adenosine Monophosphate
6%
Mitochondrion
6%
Hypocalcaemia
6%
Clinical Trial
6%
Calpain
6%
Keratinocyte
6%
Calcitriol Receptor
6%
Blood Level
6%
Cholecalciferol
5%
Oxygenase
5%